Abstract 119P
Background
Gastric cancer (GC) remains the fifth most common malignancy worldwide accounting for over 1 million new cases and an estimated 769,000 deaths by 2020. Nearly 40% of the global GC cases occur in China, and the 5-year overall survival rate is less than 50%. Lymph node metastases (LNM) is an independent risk factor for prognosis and determines which treatments can be used in GC. LNM plays a crucial gateway role in cancer spread, but the underlying roles of LNM remain controversial, and there is no worldwide consensus. Therefore, the aim of this study was to investigate the clinical perspective and significance of LNM in GC via a retrospective study.
Methods
This study was performed on 129 patients who had gastric cancer with lymphadenectomy for the radical cure, whose specimens were obtained during surgery. Dissected lymph nodes were collected in groups and histopathological studies were performed to detect the lymph node metastasis and metastatic lymph node ratio (MLR). We also analyzed the relationships between rates of lymph node metastasis and tumor diameters, tumor localization, infiltrating depth, histological category, Borrmann typing, and so on.
Results
Among 129 patients with gastric cancer, lymph node metastases were found in 80 patients (62.02%) with a total collection of 3295 lymph nodes and an average of 25.54 lymph nodes per patient. The number of lymph nodes with metastasis was 889. Lymph node metastasis was associated with tumor size, the depth of invasion, Borrmann type, location and histological type. There were correlations between the total number of lymph nodes from 129 gastric cancer patients, metastatic lymph node numbers and MLR. Analysis of the survival curve showed that the survival time and rate had a negative correlation with the TNM stage and MLR.
Conclusions
According to the clinical and pathological factors, the characteristics of lymph node metastasis by groups and stations in different areas, and properly choosing and extending the extent of lymph node resection, the objective of the radical cure for gastric cancer could be achieved individually when radical lymphadenectomy is performed.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Technology Innovation Guidance Special Program of Shaanxi Province (2022QFY01-08), Key Research and Development Program of Shaanxi Province (2021SF-288), Natural Science Basic Research Program of Shaanxi Province (2020JQ-950, 2022JM-570), Health Research Program of Shaanxi Province (2022D002).
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
48P - Long-term clinical outcomes after the second metastasectomy in patients (pts) with resected metastatic colorectal cancer (mCRC)
Presenter: Songji Choi
Session: Poster viewing 02
49P - Ramucirumab beyond progression plus TAS 102 in patients with advanced or metastatic adenocarcinoma of the stomach or the gastroesophageal junction, after treatment failure on a ramucirumab based therapy: Final results of the phase II RE-ExPEL study
Presenter: Thorsten Goetze
Session: Poster viewing 02
50P - Linear tumor regression of rectal cancer in daily MRI during preoperative chemoradiotherapy: An insight of tumor regression velocity for personalized cancer therapy
Presenter: Sea-Won Lee
Session: Poster viewing 02
51P - Efficacy and safety of sintilimab as first-line therapy in patients with microsatellite instability-high metastatic colorectal cancer: A real-world study
Presenter: Caiyun Nie
Session: Poster viewing 02
53P - Baseline PET/CT deep radiomics signature apply for identifying bevacizumab sensitivity of RAS-mutant colorectal cancer liver metastases patients
Presenter: Wenju Chang
Session: Poster viewing 02
54P - Efficacy of total neoadjuvant therapy (TNT) in rectal cancer: A meta-analysis of randomized controlled trials
Presenter: Yakup Ergün
Session: Poster viewing 02
55P - Biodegradable and biocompatible 3D-printed scaffolds loaded with chemotherapy drugs: A new horizon for treatment of colon cancer with diffuse intraperitoneal metastasis
Presenter: Amirhosein Kefayat
Session: Poster viewing 02
56P - Clinico-pathological profile of adolescent and young adult colorectal cancer patients: Multicentre collaborative registry data from India
Presenter: Soumya Surath Panda
Session: Poster viewing 02